April 10, 2018 / 11:26 AM / 5 months ago

BRIEF-Loxo Oncology And Illumina To Partner On Developing Pan Cancer Companion Diagnostics

April 10 (Reuters) - Loxo Oncology:

* LOXO ONCOLOGY AND ILLUMINA TO PARTNER ON DEVELOPING NEXT-GENERATION SEQUENCING-BASED PAN-CANCER COMPANION DIAGNOSTICS

* LOXO ONCOLOGY-PARTNERSHIP TO SEEK APPROVAL FOR VERSION OF ILLUMINA TRUSIGHT TUMOR 170 AS COMPANION DIAGNOSTIC FOR LAROTRECTINIB, LOXO-292 ACROSS TUMORS

* LOXO ONCOLOGY - COMPANIES ALSO PLANNING TO BROADEN CLINICAL UTILITY OF FULL PANEL BY OBTAINING REGULATORY APPROVAL FOR OTHER ASSAY CONTENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below